$TECH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIO-TECHNE Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BIO-TECHNE Corp. Get notifications about new insider transactions in BIO-TECHNE Corp for free.
Page: < prev 1 2 3 4 5 6 ... 8 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 07 2020 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Grant | A | 0.00 | 8,586 | 0 | 152,483 | 143.9 K to 152.5 K (+5.97 %) |
Aug 07 2020 | TECH | BIO-TECHNE Corp | Kelderman Kim | Pres. Diagnostics & ... | Option Exercise | A | 267.87 | 8,325 | 2,230,018 | 8,325 | |
Aug 07 2020 | TECH | BIO-TECHNE Corp | Kelderman Kim | Pres. Diagnostics & ... | Option Exercise | A | 267.87 | 8,325 | 2,230,018 | 8,325 | |
Aug 07 2020 | TECH | BIO-TECHNE Corp | Kelderman Kim | Pres. Diagnostics & ... | Option Exercise | A | 267.87 | 11,988 | 3,211,226 | 11,988 | |
Aug 07 2020 | TECH | BIO-TECHNE Corp | Kelderman Kim | Pres. Diagnostics & ... | Option Exercise | A | 267.87 | 8,991 | 2,408,419 | 8,991 | |
Aug 07 2020 | TECH | BIO-TECHNE Corp | Kelderman Kim | Pres. Diagnostics & ... | Option Exercise | A | 0.00 | 2,015 | 0 | 2,015 | |
Aug 07 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | A | 267.87 | 8,325 | 2,230,018 | 8,325 | |
Aug 07 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | A | 267.87 | 8,325 | 2,230,018 | 8,325 | |
Aug 07 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | A | 267.87 | 19,147 | 5,128,907 | 19,147 | |
Aug 07 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | A | 267.87 | 14,360 | 3,846,613 | 14,360 | |
Aug 07 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | A | 0.00 | 3,219 | 0 | 3,219 | |
Aug 07 2020 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | A | 267.87 | 8,325 | 2,230,018 | 8,325 | |
Aug 07 2020 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | A | 267.87 | 8,325 | 2,230,018 | 8,325 | |
Aug 07 2020 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | A | 267.87 | 9,990 | 2,676,021 | 9,990 | |
Aug 07 2020 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | A | 267.87 | 7,492 | 2,006,882 | 7,492 | |
Aug 07 2020 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | A | 0.00 | 1,679 | 0 | 1,679 | |
Aug 07 2020 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Option Exercise | A | 267.87 | 24,975 | 6,690,053 | 24,975 | |
Aug 07 2020 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Option Exercise | A | 267.87 | 24,975 | 6,690,053 | 24,975 | |
Aug 07 2020 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Option Exercise | A | 267.87 | 15,318 | 4,103,233 | 15,318 | |
Aug 07 2020 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Option Exercise | A | 267.87 | 11,488 | 3,077,291 | 11,488 | |
Aug 07 2020 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Option Exercise | A | 0.00 | 2,575 | 0 | 2,575 | |
Aug 05 2020 | TECH | BIO-TECHNE Corp | Bushman Julie L | Option Exercise | A | 278.87 | 361 | 100,672 | 361 | ||
Aug 05 2020 | TECH | BIO-TECHNE Corp | Bushman Julie L | Grant | A | 0.00 | 89 | 0 | 89 | 0 to 89 | |
Jul 13 2020 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | M | 108.49 | 9,079 | 984,981 | 921 | |
Jul 13 2020 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Sell | S | 278.84 | 74 | 20,634 | 4,311 | 4.4 K to 4.3 K (-1.69 %) |
Jul 13 2020 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Sell | S | 278.06 | 2,746 | 763,556 | 4,385 | 7.1 K to 4.4 K (-38.51 %) |
Jul 13 2020 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Sell | S | 277.28 | 1,954 | 541,812 | 7,131 | 9.1 K to 7.1 K (-21.51 %) |
Jul 13 2020 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Sell | S | 276.03 | 400 | 110,410 | 9,085 | 9.5 K to 9.1 K (-4.22 %) |
Jul 13 2020 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Sell | S | 274.81 | 918 | 252,271 | 9,485 | 10.4 K to 9.5 K (-8.82 %) |
Jul 13 2020 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Sell | S | 273.33 | 2,042 | 558,143 | 10,403 | 12.4 K to 10.4 K (-16.41 %) |
Jul 13 2020 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Sell | S | 272.48 | 505 | 137,601 | 12,445 | 13 K to 12.4 K (-3.90 %) |
Jul 13 2020 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Sell | S | 270.97 | 440 | 119,225 | 12,950 | 13.4 K to 13 K (-3.29 %) |
Jul 13 2020 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Buy | M | 108.49 | 9,079 | 984,981 | 13,390 | 4.3 K to 13.4 K (+210.60 %) |
Jul 08 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | M | 108.49 | 2,577 | 279,579 | 15,909 | |
Jul 08 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | M | 108.49 | 21,502 | 2,332,752 | 18,486 | |
Jul 08 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 272.26 | 500 | 136,130 | 9,307 | 9.8 K to 9.3 K (-5.10 %) |
Jul 08 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 271.40 | 1,663 | 451,341 | 9,807 | 11.5 K to 9.8 K (-14.50 %) |
Jul 08 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 270.56 | 414 | 112,010 | 11,470 | 11.9 K to 11.5 K (-3.48 %) |
Jul 08 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Buy | M | 108.49 | 2,577 | 279,579 | 11,884 | 9.3 K to 11.9 K (+27.69 %) |
Jul 08 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 274.52 | 1,269 | 348,363 | 9,307 | 10.6 K to 9.3 K (-12.00 %) |
Jul 08 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 273.71 | 1,934 | 529,358 | 10,576 | 12.5 K to 10.6 K (-15.46 %) |
Jul 08 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 272.34 | 4,947 | 1,347,256 | 12,510 | 17.5 K to 12.5 K (-28.34 %) |
Jul 08 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 271.53 | 3,781 | 1,026,667 | 17,457 | 21.2 K to 17.5 K (-17.80 %) |
Jul 08 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 270.45 | 9,571 | 2,588,508 | 21,238 | 30.8 K to 21.2 K (-31.07 %) |
Jul 08 2020 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Buy | M | 108.49 | 21,502 | 2,332,752 | 30,809 | 9.3 K to 30.8 K (+231.03 %) |
Jun 02 2020 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Option Exercise | M | 101.19 | 3,985 | 403,242 | 0 | ||
Jun 02 2020 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Sell | S | 260.00 | 3,985 | 1,036,100 | 4,843 | 8.8 K to 4.8 K (-45.14 %) | |
Jun 02 2020 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Buy | M | 101.19 | 3,985 | 403,242 | 8,828 | 4.8 K to 8.8 K (+82.28 %) | |
Jun 02 2020 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Gift | G | 0.00 | 378 | 0 | 4,843 | 5.2 K to 4.8 K (-7.24 %) | |
Jun 01 2020 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | M | 108.49 | 5,995 | 650,398 | 10,000 | |
Jun 01 2020 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | M | 94.35 | 1,600 | 150,960 | 0 | |
Jun 01 2020 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Sell | S | 260.38 | 3,800 | 989,454 | 4,311 | 8.1 K to 4.3 K (-46.85 %) |
Jun 01 2020 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Sell | S | 259.72 | 2,195 | 570,079 | 8,111 | 10.3 K to 8.1 K (-21.30 %) |
Jun 01 2020 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Buy | M | 94.35 | 1,600 | 150,960 | 10,306 | 8.7 K to 10.3 K (+18.38 %) |
Jun 01 2020 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Buy | M | 108.49 | 5,995 | 650,398 | 8,706 | 2.7 K to 8.7 K (+221.14 %) |
Jun 01 2020 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Option Exercise | M | 108.49 | 7,909 | 858,047 | 0 | |
Jun 01 2020 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Option Exercise | M | 108.49 | 3,448 | 374,074 | 7,909 | |
Jun 01 2020 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Sell | S | 264.01 | 709 | 187,184 | 0 | 709 to 0 (-100.00 %) |
Jun 01 2020 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Sell | S | 262.68 | 2,100 | 551,619 | 709 | 2.8 K to 709 (-74.76 %) |
Jun 01 2020 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Sell | S | 261.74 | 3,400 | 889,927 | 2,809 | 6.2 K to 2.8 K (-54.76 %) |
Jun 01 2020 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Sell | S | 260.83 | 1,700 | 443,410 | 6,209 | 7.9 K to 6.2 K (-21.49 %) |
Jun 01 2020 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Buy | M | 108.49 | 7,909 | 858,047 | 7,909 | 0 to 7.9 K |
Jun 01 2020 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Sell | S | 260.19 | 3,448 | 897,134 | 0 | 3.4 K to 0 (-100.00 %) |
Jun 01 2020 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Buy | M | 108.49 | 3,448 | 374,074 | 3,448 | 0 to 3.4 K |
May 28 2020 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | M | 86.25 | 21,159 | 1,824,964 | 25,157 | |
May 28 2020 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | M | 86.25 | 21,159 | 1,824,964 | 25,157 | |
May 28 2020 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Payment of Exercise | F | 266.40 | 13,018 | 3,467,995 | 138,130 | 151.1 K to 138.1 K (-8.61 %) |
May 28 2020 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Payment of Exercise | F | 266.40 | 13,018 | 3,467,995 | 138,130 | 151.1 K to 138.1 K (-8.61 %) |
May 28 2020 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Buy | M | 86.25 | 21,159 | 1,824,964 | 151,148 | 130 K to 151.1 K (+16.28 %) |
May 28 2020 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Buy | M | 86.25 | 21,159 | 1,824,964 | 151,148 | 130 K to 151.1 K (+16.28 %) |
May 26 2020 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Option Exercise | M | 108.49 | 8,637 | 937,028 | 11,357 | |
May 26 2020 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Option Exercise | M | 94.35 | 3,963 | 373,909 | 0 | |
May 26 2020 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Option Exercise | M | 94.35 | 11,037 | 1,041,341 | 3,963 | |
May 26 2020 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Sell | S | 268.41 | 4,924 | 1,321,636 | 0 | 4.9 K to 0 (-100.00 %) |
May 26 2020 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Sell | S | 267.63 | 7,676 | 2,054,290 | 4,924 | 12.6 K to 4.9 K (-60.92 %) |
May 26 2020 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Buy | M | 108.49 | 8,637 | 937,028 | 12,600 | 4 K to 12.6 K (+217.94 %) |
May 26 2020 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Buy | M | 94.35 | 3,963 | 373,909 | 3,963 | 0 to 4 K |
May 26 2020 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Sell | S | 268.89 | 900 | 241,997 | 0 | 900 to 0 (-100.00 %) |
May 26 2020 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Sell | S | 267.37 | 10,137 | 2,710,320 | 900 | 11 K to 900 (-91.85 %) |
May 26 2020 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Buy | M | 94.35 | 11,037 | 1,041,341 | 11,037 | 0 to 11 K |
May 26 2020 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Director | Option Exercise | M | 70.35 | 5,000 | 351,750 | 0 | |
May 26 2020 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Director | Sell | S | 267.94 | 125 | 33,493 | 9,221 | 9.3 K to 9.2 K (-1.34 %) |
May 26 2020 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Director | Sell | S | 267.32 | 1,974 | 527,685 | 9,346 | 11.3 K to 9.3 K (-17.44 %) |
May 26 2020 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Director | Sell | S | 266.07 | 1,601 | 425,979 | 11,320 | 12.9 K to 11.3 K (-12.39 %) |
May 26 2020 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Director | Sell | S | 265.35 | 1,300 | 344,960 | 12,921 | 14.2 K to 12.9 K (-9.14 %) |
May 26 2020 | TECH | BIO-TECHNE Corp | BAUMGARTNER ROBERT V | Director | Buy | M | 70.35 | 5,000 | 351,750 | 14,221 | 9.2 K to 14.2 K (+54.22 %) |
May 08 2020 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Option Exercise | M | 87.34 | 4,260 | 372,068 | 0 | ||
May 08 2020 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Sell | S | 250.00 | 4,260 | 1,065,000 | 5,221 | 9.5 K to 5.2 K (-44.93 %) | |
May 08 2020 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Buy | M | 87.34 | 4,260 | 372,068 | 9,481 | 5.2 K to 9.5 K (+81.59 %) | |
May 05 2020 | TECH | BIO-TECHNE Corp | Kelderman Kim | Pres. Diagnostics & ... | Option Exercise | M | 0.00 | 1,666 | 0 | 1,667 | |
May 05 2020 | TECH | BIO-TECHNE Corp | Kelderman Kim | Pres. Diagnostics & ... | Payment of Exercise | F | 227.54 | 821 | 186,810 | 1,668 | 2.5 K to 1.7 K (-32.99 %) |
May 05 2020 | TECH | BIO-TECHNE Corp | Kelderman Kim | Pres. Diagnostics & ... | Buy | M | 0.00 | 1,666 | 0 | 2,489 | 823 to 2.5 K (+202.43 %) |
Mar 06 2020 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Sell | S | 198.68 | 1,387 | 275,569 | 0 | 1.4 K to 0 (-100.00 %) |
Feb 14 2020 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Director | Option Exercise | M | 61.46 | 5,000 | 307,300 | 0 | |
Feb 14 2020 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Director | Sell | S | 205.23 | 5,000 | 1,026,133 | 4,021 | 9 K to 4 K (-55.43 %) |
Feb 14 2020 | TECH | BIO-TECHNE Corp | HIGGINS JOHN L | Director | Buy | M | 61.46 | 5,000 | 307,300 | 9,021 | 4 K to 9 K (+124.35 %) |
Jan 08 2020 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | M | 67.46 | 10,276 | 693,219 | 100 | |
Jan 08 2020 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Sell | S | 217.28 | 10,276 | 2,232,769 | 129,989 | 140.3 K to 130 K (-7.33 %) |
Jan 08 2020 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Buy | M | 67.46 | 10,276 | 693,219 | 140,265 | 130 K to 140.3 K (+7.91 %) |
Dec 27 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | M | 67.46 | 471 | 31,774 | 38,218 | |
Dec 27 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | M | 67.46 | 659 | 44,456 | 38,689 | |
Dec 27 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Sell | S | 222.18 | 471 | 104,648 | 129,989 | 130.5 K to 130 K (-0.36 %) |
Dec 27 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Buy | M | 67.46 | 471 | 31,774 | 130,460 | 130 K to 130.5 K (+0.36 %) |
Dec 27 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Sell | S | 222.08 | 659 | 146,351 | 129,989 | 130.6 K to 130 K (-0.50 %) |
Dec 27 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Buy | M | 67.46 | 659 | 44,456 | 130,648 | 130 K to 130.6 K (+0.51 %) |
Dec 23 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | M | 67.46 | 5,767 | 389,042 | 39,348 | |
Dec 23 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Sell | S | 222.06 | 5,767 | 1,280,632 | 129,989 | 135.8 K to 130 K (-4.25 %) |
Dec 23 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Buy | M | 67.46 | 5,767 | 389,042 | 135,756 | 130 K to 135.8 K (+4.44 %) |
Dec 23 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | M | 67.46 | 5,767 | 389,042 | 39,348 | |
Dec 23 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Sell | S | 222.06 | 5,767 | 1,280,632 | 129,989 | 135.8 K to 130 K (-4.25 %) |
Dec 23 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Buy | M | 67.46 | 5,767 | 389,042 | 135,756 | 130 K to 135.8 K (+4.44 %) |
Dec 17 2019 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | M | 94.35 | 8,000 | 754,800 | 1,600 | |
Dec 17 2019 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Sell | S | 216.75 | 200 | 43,350 | 2,711 | 2.9 K to 2.7 K (-6.87 %) |
Dec 17 2019 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Sell | S | 216.01 | 4,147 | 895,784 | 2,911 | 7.1 K to 2.9 K (-58.76 %) |
Dec 17 2019 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Sell | S | 215.17 | 3,227 | 694,338 | 7,058 | 10.3 K to 7.1 K (-31.38 %) |
Dec 17 2019 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Sell | S | 214.32 | 426 | 91,300 | 10,285 | 10.7 K to 10.3 K (-3.98 %) |
Dec 17 2019 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Buy | M | 94.35 | 8,000 | 754,800 | 10,711 | 2.7 K to 10.7 K (+295.09 %) |
Dec 17 2019 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Gift | G | 0.00 | 492 | 0 | 2,711 | 3.2 K to 2.7 K (-15.36 %) |
Dec 12 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | M | 67.46 | 703 | 47,424 | 45,115 | |
Dec 12 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Sell | S | 222.01 | 703 | 156,073 | 135,756 | 136.5 K to 135.8 K (-0.52 %) |
Dec 12 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Buy | M | 67.46 | 703 | 47,424 | 136,459 | 135.8 K to 136.5 K (+0.52 %) |
Dec 06 2019 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Director | Option Exercise | M | 87.83 | 2,000 | 175,660 | 0 | |
Dec 06 2019 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Director | Sell | S | 219.31 | 80 | 17,545 | 5,221 | 5.3 K to 5.2 K (-1.51 %) |
Dec 06 2019 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Director | Sell | S | 218.76 | 921 | 201,473 | 5,301 | 6.2 K to 5.3 K (-14.80 %) |
Dec 06 2019 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Director | Sell | S | 217.29 | 514 | 111,685 | 6,222 | 6.7 K to 6.2 K (-7.63 %) |
Dec 06 2019 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Director | Sell | S | 216.48 | 485 | 104,990 | 6,736 | 7.2 K to 6.7 K (-6.72 %) |
Dec 06 2019 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Director | Buy | M | 87.83 | 2,000 | 175,660 | 7,221 | 5.2 K to 7.2 K (+38.31 %) |
Dec 06 2019 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Director | Option Exercise | M | 87.83 | 2,000 | 175,660 | 0 | |
Dec 06 2019 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Director | Sell | S | 219.31 | 80 | 17,545 | 5,221 | 5.3 K to 5.2 K (-1.51 %) |
Dec 06 2019 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Director | Sell | S | 218.76 | 921 | 201,473 | 5,301 | 6.2 K to 5.3 K (-14.80 %) |
Dec 06 2019 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Director | Sell | S | 217.29 | 514 | 111,685 | 6,222 | 6.7 K to 6.2 K (-7.63 %) |
Dec 06 2019 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Director | Sell | S | 216.48 | 485 | 104,990 | 6,736 | 7.2 K to 6.7 K (-6.72 %) |
Dec 06 2019 | TECH | BIO-TECHNE Corp | WIENS HAROLD J | Director | Buy | M | 87.83 | 2,000 | 175,660 | 7,221 | 5.2 K to 7.2 K (+38.31 %) |
Dec 02 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | M | 67.46 | 11,772 | 794,139 | 45,818 | |
Dec 02 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Sell | S | 222.62 | 100 | 22,262 | 135,756 | 135.9 K to 135.8 K (-0.07 %) |
Dec 02 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Sell | S | 222.12 | 11,772 | 2,614,814 | 135,856 | 147.6 K to 135.9 K (-7.97 %) |
Dec 02 2019 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Buy | M | 67.46 | 11,772 | 794,139 | 147,628 | 135.9 K to 147.6 K (+8.67 %) |
Nov 29 2019 | TECH | BIO-TECHNE Corp | Nusse Roeland | Director | Option Exercise | M | 61.46 | 5,000 | 307,300 | 0 | |
Nov 29 2019 | TECH | BIO-TECHNE Corp | Nusse Roeland | Director | Option Exercise | M | 60.46 | 10,000 | 604,600 | 0 | |
Nov 29 2019 | TECH | BIO-TECHNE Corp | Nusse Roeland | Director | Sell | S | 219.33 | 8,347 | 1,830,731 | 12,374 | 20.7 K to 12.4 K (-40.28 %) |
Nov 29 2019 | TECH | BIO-TECHNE Corp | Nusse Roeland | Director | Buy | M | 61.46 | 5,000 | 307,300 | 20,721 | 15.7 K to 20.7 K (+31.80 %) |
Nov 29 2019 | TECH | BIO-TECHNE Corp | Nusse Roeland | Director | Buy | M | 60.46 | 10,000 | 604,600 | 15,721 | 5.7 K to 15.7 K (+174.79 %) |
Nov 25 2019 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | M | 94.35 | 23,651 | 2,231,472 | 0 | |
Nov 25 2019 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | M | 94.35 | 11,349 | 1,070,778 | 23,651 | |
Nov 25 2019 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 216.16 | 1,600 | 345,850 | 9,307 | 10.9 K to 9.3 K (-14.67 %) |
Nov 25 2019 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 215.55 | 22,051 | 4,753,051 | 10,907 | 33 K to 10.9 K (-66.91 %) |
Nov 25 2019 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Buy | M | 94.35 | 23,651 | 2,231,472 | 32,958 | 9.3 K to 33 K (+254.12 %) |
Nov 25 2019 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 215.36 | 11,349 | 2,444,132 | 9,307 | 20.7 K to 9.3 K (-54.94 %) |
Nov 25 2019 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Buy | M | 94.35 | 11,349 | 1,070,778 | 20,656 | 9.3 K to 20.7 K (+121.94 %) |
Oct 28 2019 | TECH | BIO-TECHNE Corp | KEEGAN JOSEPH D | Director | Option Exercise | A | 201.64 | 2,011 | 405,498 | 2,011 |